Jul 3 |
Lilly's new Alzheimer's drug could generate $7.1B in sales: analyst
|
Jul 3 |
S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday?
|
Jul 3 |
Novo Nordisk, Eli Lilly Tumble After Study Suggests Weight-Loss Drugs Can Lead To Blindness
|
Jul 3 |
Weight-loss drugs linked to rare vision loss: Harvard study
|
Jul 3 |
ADP jobs data, Constellation Brands, summer gas prices: Morning Brief
|
Jul 3 |
Ozempic Linked to Rare Cases of Vision Loss in Harvard Study
|
Jul 3 |
FDA Approves Eli Lilly's Alzheimer's Drug Kisunla
|
Jul 3 |
Top 3 Health Care Stocks That May Crash This Quarter
|
Jul 3 |
Eli Lilly (LLY) Gets FDA Nod for Alzheimer's Drug Donanemab
|
Jul 3 |
5 Things to Know Before the Stock Market Opens
|